Xiangyun Kong Selected Research

Xiangyun Kong Research Topics

6	Nasopharyngeal Carcinoma 02/2024 - 01/2020
2	Myocardial Infarction 01/2023 - 01/2021
2	Death (Near-Death Experience) 01/2023 - 01/2021
2	Thrombosis (Thrombus) 01/2023 - 01/2021
1	Disease Progression 02/2024
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Non-ST Elevated Myocardial Infarction 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Acute Coronary Syndrome 08/2022
1	Dysbiosis 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Atrial Fibrillation 01/2021
1	Colitis 10/2014
1	Wounds and Injuries (Trauma) 01/2014
1	Carcinoma (Carcinomatosis) 05/2013

2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2023
1	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 10/2023
1	camrelizumabIBA 01/2023
1	apatinibIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	AlbuminsIBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	AnticoagulantsIBA 01/2021
1	Caspase 9IBA 01/2021
1	Sulfonic AcidsIBA 10/2014
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 10/2014
1	2-aminoethoxydiphenyl borateIBA 01/2014
1	Messenger RNA (mRNA)IBA 05/2013
1	Proteins (Proteins, Gene)FDA Link 05/2013

3	Stents 01/2023 - 01/2021
2	Chemoradiotherapy 02/2024 - 01/2020
2	Radiotherapy 02/2024 - 10/2023
2	Therapeutics 02/2024 - 11/2023
2	Drug Therapy (Chemotherapy) 02/2024 - 10/2023
1	Induction Chemotherapy 02/2024
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2024
1	Immunotherapy 11/2023